Arkolith/Insider Trading/BOLT/Form 4

Quinn William P.

President, CEO and CFO, DirectorBolt Biotherapeutics, Inc. (BOLT) · full profile →Form 4 · filed Dec 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
0 non-derivative · 16 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)8K——8K
Dec 12, 2025Disposed to issuer(D)8K——0
Dec 12, 2025Grant(A)4K——4K
Dec 12, 2025Disposed to issuer(D)4K——0
Dec 12, 2025Grant(A)5K——5K
Dec 12, 2025Disposed to issuer(D)5K——0
Dec 12, 2025Grant(A)10K——10K
Dec 12, 2025Disposed to issuer(D)10K——0
Dec 12, 2025Grant(A)12K——12K
Dec 12, 2025Disposed to issuer(D)12K——0
Dec 12, 2025Grant(A)12K——12K
Dec 12, 2025Disposed to issuer(D)12K——0
Dec 12, 2025Grant(A)22K——22K
Dec 12, 2025Disposed to issuer(D)22K——0
Dec 12, 2025Grant(A)35K——35K
Dec 12, 2025Disposed to issuer(D)35K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-321146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML